Popular Articles

May 01, 2011
Pharmaceutical Executive
Stiff price tags draw scrutiny from Congress and consumers, and raise questions about FDA policies
May 01, 2011
Pharmaceutical Executive
Who's taken this year's top spot? Find out in Pharm Exec's annual run-down of the world's Top 50 pharma companies.
May 01, 2011
Pharmaceutical Executive
Why is building a successful marketing program so difficult? It should be simple, if your product is worth marketing.
May 01, 2011
Pharmaceutical Executive
The UK coalition government's consultation on the intro of value-based pricing has invited caution and resistance
Mar 01, 2011
Pharmaceutical Executive
Can PhRMA's own business model synch with industry's Pharm Exec takes a closer look at PhRMA's new leadership.
Mar 01, 2011
Pharmaceutical Executive
Pharma can be an insular industry, with limited capacity to gaze beyond its own narrow frame of vision
Mar 01, 2011
Pharmaceutical Executive
When dealing with the pharmaceutical marketplace, why is keeping things simple so complex?
Mar 01, 2011
Pharmaceutical Executive
With an emphasis on short-term objectives rather than long-term goals, pharma is missing a huge opportunity in applying market science to drive adherence
Feb 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
To manage through a resource-constrained environment, it is essential to get the most out of procurement planning
Feb 01, 2011
Pharmaceutical Executive
Novartis' Gilenya is a step forward in treating Multiple Sclerosis. But generating increased compliance is another story
native1_300x100
lorem ipsum